Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - tasonermin - powder and solvent for solution for infusion - 1mg

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - tasonermin - powder for solution for infusion - 1mg

Uniunea Europeană - engleză - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone.in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets.in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).

Uniunea Europeană - engleză - EMA (European Medicines Agency)

teva b.v.  - oxybutynin - urinary incontinence, urge - urologicals - symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - leflunomide - arthritis, rheumatoid - selective immunosuppressants - leflunomide is indicated for the treatment of adult patients with:active rheumatoid arthritis as a 'disease-modifying antirheumatic drug' (dmard).recent or concurrent treatment with hepatotoxic or haematotoxic dmards (e.g. methotrexate) may result in an increased risk of serious adverse reactions, therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects.moreover, switching from leflunomide to another dmard without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.

Uniunea Europeană - engleză - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - tovanor breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Uniunea Europeană - engleză - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance.in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).

Uniunea Europeană - engleză - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asthma - drugs for obstructive airway diseases, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Panama - engleză - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

mercantil farmaceutica, s.a. - dexibuprofeno - dexibuprofeno....400.00 miligramo

Panama - engleză - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

mercantil farmaceutica, s.a. - dexibuprofeno - dexibuprofeno....400,00 mg